[18F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 3, 2011, Pages 615-622

  Terezakis, Stephanie A ^a   Hunt, Margie A ^a   Kowalski, Alexander ^a   McCann, Patrick ^a   Schmidtlein, C Ross ^a   Reiner, Anne ^a   Gönen, Mithat ^a   Kirov, Assen S ^a   Gonzales, Anne Marie ^a   Schöder, Heiko ^a   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

18F FDG PET; Involved field radiation; Lymphoma; PET CT radiation planning; Target volume definition

Indexed keywords

ADDITIONAL TREATMENT; COMPUTED TOMOGRAPHY; COMPUTED TOMOGRAPHY SCAN; COREGISTRATION; DISEASE DETECTION; EMISSION TOMOGRAPHY; FDG-PET; GROSS TUMOR VOLUME; INVOLVED FIELD; LYMPHOMA; NON-HODGKIN LYMPHOMA; NORMAL TISSUE; PET SCAN; PLANNING TARGET VOLUMES; PLASMA CELLS; RADIATION ONCOLOGISTS; RADIATION TREATMENT PLANNING; RADIATION TREATMENTS; SENSITIVITY AND SPECIFICITY; TARGET VOLUME DEFINITION; TREATMENT PLANNING; TREATMENT PLANS; TREATMENT SITES;

COMPUTERIZED TOMOGRAPHY; DOSIMETRY; ONCOLOGY; POSITRONS; RADIOTHERAPY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FEMALE; HEMATOLOGIC MALIGNANCY; HISTOGRAM; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PLASMACYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION TREATMENT PLANNING; RETROSPECTIVE STUDY; SIMULATION; TREATMENT PLANNING; TUMOR VOLUME; CANCER CENTER; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS, PLASMA CELL; NEW YORK CITY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TUMOR BURDEN; YOUNG ADULT;

EID: 80053608278     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.044     Document Type: Article

References (28)

1. G. Jerusalem, Y. Beguin, and M.F. Fassotte Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease Haematologica 86 2001 266 273 (Pubitemid 32291064)
2. M.R. Weihrauch, D. Re, and S. Bischoff Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease Ann Hematol 81 2002 20 25 (Pubitemid 36075491)
3. A. Wirth, J.F. Seymour, and R.J. Hicks Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma Am J Med 112 2002 262 268 (Pubitemid 34219438)
4. M. Sasaki, Y. Kuwabara, and H. Koga Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma Ann Nucl Med 16 2002 337 345 (Pubitemid 34988272)
5. H. Schoder, J. Meta, and C. Yap Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma J Nucl Med 42 2001 1139 1143 (Pubitemid 32717828)
6. C. Schiepers, J. Filmont, and J. Czernin PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma Eur J Nucl Med Mol Imaging 30 Suppl 1 2003 S82 S88
7. J. Yahalom, and P. Mauch The involved field is back: Issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13 Suppl 1 2002 79 83 (Pubitemid 34567406)
8. B.S. Hoppe, C.H. Moskowitz, and Z. Zhang The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma Bone Marrow Transplant 43 2009 941 948
9. M. Koshy, A.C. Paulino, and R. Howell Volumetric analysis of the PET-CT defined target in intensity modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 60 Suppl 2004 S492
10. K. Mah, C.B. Caldwell, and Y.C. Ung The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study Int J Radiat Oncol Biol Phys 52 2002 339 350 (Pubitemid 34172999)
11. I.F. Ciernik, E. Dizendorf, and B.G. Baumert Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study Int J Radiat Oncol Biol Phys 57 2003 853 863 (Pubitemid 37194314)
12. A. van Der Wel, S. Nijsten, and M. Hochstenbag Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study Int J Radiat Oncol Biol Phys 61 2005 649 655 (Pubitemid 40247958)
13. J. Bradley, W.L. Thorstad, and S. Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86 (Pubitemid 38501510)
14. A. van Baardwijk, B.G. Baumert, and G. Bosmans The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning Cancer Treat Rev 32 2006 245 260 (Pubitemid 44502002)
15. A.C. Paulino, M. Koshy, and R. Howell Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 61 2005 1385 1392 (Pubitemid 40470419)
16. D.E. Heron, R.S. Andrade, and J. Flickinger Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report Int J Radiat Oncol Biol Phys 60 2004 1419 1424 (Pubitemid 39601859)
17. J.F. Daisne, T. Duprez, and B. Weynand Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen Radiology 233 2004 93 100 (Pubitemid 39280962)
18. L.J. Vanuytsel, J.F. Vansteenkiste, and S.G. Stroobants The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer Radiother Oncol 55 2000 317 324 (Pubitemid 30408377)
19. D.L. Schwartz, E. Ford, and J. Rajendran FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 61 2005 129 136 (Pubitemid 40039114)
20. C. Scarfone, W.C. Lavely, and A.J. Cmelak Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging J Nucl Med 45 2004 543 552 (Pubitemid 47618583)
21. Y.K. Lee, G. Cook, and M.A. Flower Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma Radiother Oncol 73 2004 277 283 (Pubitemid 39601074)
22. M. Hutchings, A. Loft, and M. Hansen Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma Eur J Haematol 78 2007 206 212
23. E.V. Dizendorf, B.G. Baumert, and G.K. von Schulthess Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy J Nucl Med 44 2003 24 29 (Pubitemid 36077708)
24. E. Brianzoni, G. Rossi, and S. Ancidei Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume Eur J Nucl Med Mol Imaging 32 2005 1392 1399 (Pubitemid 41746842)
25. T. Girinsky, M. Ghalibafian, and G. Bonniaud Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting? Radiother Oncol 85 2007 178 186 (Pubitemid 350160993)
26. Y.E. Erdi, K. Rosenzweig, and A.K. Erdi Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) Radiother Oncol 62 2002 51 60 (Pubitemid 34121949)
27. J.L. Fox, R. Rengan, and W. O'Meara Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? Int J Radiat Oncol Biol Phys 62 2005 70 75 (Pubitemid 40591925)
28. A. Noy, H. Schoder, and M. Gonen The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL) Ann Oncol 20 2009 508 512